Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01560416
Title Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
DFCI at Faulkner Hospital Boston Massachusetts 02130 United States Details
Brigham and Women's Hospital Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
New Hampshire Oncology and Hematology, P.A. Concord New Hampshire 03301 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field